ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
0.0235
-0.0005
( -2.08% )
更新日時: 13:00:03

Syntara Ltd (SNT) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.0235
( -2.08% )
買値
0.023
売値
0.031
出来高
118,519
0.023 日の範囲 0.0235
0.023 52 週間の範囲 0.083
時価総額
前日終値
0.024
始値
0.023
最終取引時間
13:00:02
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 1,358,627
発行済株式数
1,876,980,111
配当利回り
PER
-2.9
1 株当たり利益 (EPS)
-0.01
歳入
7.5M
純利益
-11.06M

Syntara Ltd について

Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product ca... Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product candidate, amsulostat, is being developed for the treatment of bone marrow cancer myelofibrosis and is in Phase 1c/2 studies for patients with myelodysplastic syndrome. The company also develops topical pan-LOX inhibitors with SNT-9465, which is in a Phase 1a/b study for hypertrophic scars; SNT-6302 for keloid scars; and SNT-4728 to treat sleep disorders and slow progression of neurodegenerative diseases by reducing neuroinflammation. In addition, it develops other drug candidates that target fibrotic and inflammatory diseases, including kidney fibrosis, MASH, pulmonary fibrosis, and cardiac fibrosis. The company was formerly known as Pharmaxis Ltd and changed its name to Syntara Limited in December 2023. Syntara Limited was incorporated in 1998 and is headquartered in Frenchs Forest, Australia. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Frenchs Forest, Australia
設立
1998
Syntara Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker SNT. The last closing price for Syntara was AUD0.02. Over the last year, Syntara shares have traded in a share price range of AUD 0.023 to AUD 0.083.

Syntara currently has 1,876,980,111 shares in issue. The market capitalisation of Syntara is AUD44.11 million. Syntara has a price to earnings ratio (PE ratio) of -2.90.

SNT 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0025-9.615384615380.0260.0260.02324180540.02488642DE
4-0.003-11.3207547170.02650.0270.02316727850.02552109DE
12-0.0075-24.19354838710.0310.0340.02314578200.02726829DE
26-0.0075-24.19354838710.0310.0360.02313087500.02976813DE
52-0.0465-66.42857142860.070.0830.02331044590.03740551DE
156-0.0045-16.07142857140.0280.0950.01434944190.04682624DE
260-0.0045-16.07142857140.0280.0950.01434944190.04682624DE

SNT - Frequently Asked Questions (FAQ)

What is the current Syntara Ltd share price?
The current share price of Syntara Ltd is AUD 0.0235
How many Syntara Ltd shares are in issue?
Syntara Ltd has 1,876,980,111 shares in issue
What is the market cap of Syntara Ltd?
The market capitalisation of Syntara Ltd is AUD 44.11M
What is the 1 year trading range for Syntara Ltd share price?
Syntara Ltd has traded in the range of AUD 0.023 to AUD 0.083 during the past year
What is the PE ratio of Syntara Ltd?
The price to earnings ratio of Syntara Ltd is -2.9
What is the cash to sales ratio of Syntara Ltd?
The cash to sales ratio of Syntara Ltd is 6.26
What is the registered address of Syntara Ltd?
The registered address for Syntara Ltd is 20A Rodborough Road, Frenchs Forest, New South Wales, 2086
What is the Syntara Ltd website address?
The website address for Syntara Ltd is syntaratx.com.au
Which industry sector does Syntara Ltd operate in?
Syntara Ltd operates in the Pharmaceuticals sector

SNT 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock